Philip Friedlander - Publications, H-index & Citations

Philip Friedlander

Mount Sinai Medical Center

32H指数

180论文数

8.2K被引数

收录论文 28

发表时间

The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): a randomized open-label phase 2 study 端粒酶疫苗UV1与伊匹木单抗和纳武利尤单抗联用对比伊匹木单抗和纳武利尤单抗治疗晚期黑色素瘤（INITIUM）：一项随机开放标签II期研究

European Journal of Cancer

IF7.1

2025-12-03

PREAI

Paul Lorigan; Theresa Michelle Medina; Marta Nyakas; Annemie Rutten; Lynn G. Feun; Charles Lance Cowey; Miranda Payne; Israr Hussain; Timothy Kuzel; Steven O’Day; Amna Sheri; Philip Adam Friedlander; Satish Kumar; Vanja Sue Bergersen; Øivind Foss; Espen Basmo Ellingsen; Jens Bjørheim; Oliver Edgar Bechter

Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma

FRONTIERS IN ONCOLOGY

IF3.3

2024-05-15

OAAI

Sussman, Tamara A.; Severgnini, Mariano; Giobbie-Hurder, Anita; Friedlander, Philip; Swanson, Scott J.; Jaklitsch, Michael; Clancy, Thomas; Goguen, Laura A.; Lautz, David; Swanson, Richard; Daley, Heather; Ritz, Jerome; Dranoff, Glenn; Hodi, F. Stephen

Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone

FRONTIERS IN ONCOLOGY

IF3.3

2024-05-10

OAAI

Poplausky, Dina; Young, Jade N.; Block, Brandon R.; Estrada, Yeriel; Singer, Giselle K.; Wong, Vicky; Cabral, Patricia; Suemitsu, Yamato; Kim, Randie H.; Friedlander, Philip; Gulati, Nicholas

Immunogenicity of PGV_001 neoantigen vaccine in a Phase-I clinical trial, across various types of cancers in adjuvant setting

CANCER RESEARCH

IF16.6

2023-04-14

PREAI

Saxena, Mansi; Marron, Thomas; Kodysh, Julia; Rubinsteyn, Alex; Finnigan, John; Blasquez, Ana; Meseck, Marcia; O'Donnell, Tim; Delbeau, Daniela; Galsky, Mathew; Doroshow, Deborah; Miles, Brett; Misiukiewicz, Krzysztof; Irie, Hanna; Tiersten, Amy; Parekh, Samir; Posner, Marshall; Wolf, Andrea; Mandeli, John; Brody, Rachel; Gnjatic, Sacha; Schadt, Eric; Friedlander, Philip; Bhardwaj, Nina

INTRATUMORAL IMMUNE THERAPY FOR RECURRENT BREAST CANCER WITH POLYICLC, AND TREMELIMUMAB COMBINED WITH SYSTEMIC DURVALUMAB

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-10

OAAI

Slingluff, Craig; Mauldin, Ileana; Gaughan, Elizabeth; Dillon, Patrick; Opyrchal, Mateusz; Puzanov, Igor; Kruse, Megan; Gastman, Brian; Friedlander, Philip; Marron, Thomas; Aufiero, Kristen; Macri, Mary; Schwarzenberger, Paul; Ricciardi, Toni; Ryan, Aileen; Venhaus, Ralph; Saxena, Mansi; Edmonds, Nicole; Bhardwaj, Nina

Hematological immune related adverse events after treatment with immune checkpoint inhibitors

EUROPEAN JOURNAL OF CANCER

IF7.1

2021-04-01

PREAI

Kramer, Rafaela; Zaremba, Anne; Moreira, Alvaro; Ugurel, Selma; Johnson, Douglas B.; Hassel, Jessica C.; Salzmann, Martin; Gesierich, Anja; Weppler, Alison; Spain, Lavinia; Loquai, Carmen; Dudda, Milena; Pfoehler, Claudia; Hepner, Adriana; Long, Georgina, V; Menzies, Alexander M.; Carlino, Matteo S.; Sachse, Michael M.; Lebbe, Celeste; Baroudjian, Barouyr; Enokida, Tomohiro; Tahara, Makoto; Schlaak, Max; Hayani, Kinan; Broeckelmann, Paul J.; Meier, Friedegund; Reinhardt, Lydia; Friedlander, Philip; Eigentler, Thomas; Kaehler, Katharina C.; Berking, Carola; Zimmer, Lisa; Heinzerling, Lucie

A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

ONCOIMMUNOLOGY

IF6.3

2021-03-26

OAAI

Slingluff, Craig L., Jr.; Zarour, Hassane M.; Tawbi, Hussein Abdul-Hassan; Kirkwood, John M.; Postow, Michael A.; Friedlander, Philip; Devoe, Craig E.; Gaughan, Elizabeth M.; Mauldin, Ileana S.; Olson, Walter C., Jr.; Smith, Kelly T.; Macri, Mary J.; Ricciardi, Toni; Ryan, Aileen; Venhaus, Ralph; Wolchok, Jedd D.

TALIMOGENE LAHERPAREPVEC (T-VEC) IN COMBINATION WITH IPILIMUMAB (IPI) VERSUS IPI ALONE FOR ADVANCED MELANOMA: 4-YEAR INTERIM ANALYSIS OF A RANDOMIZED, OPEN-LABEL, PHASE 2 TRIAL

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2020-12-10

PREAI

Puzanov, Igor; Chesney, Jason; Collichio, Frances; Singh, Parminder; Milhem, Mohammed; Glaspy, John; Hamid, Omid; Ross, Merrick; Friedlander, Philip; Garbe, Claus; Logan, Theodore; Hauschild, Axel; Lebbe, Celeste; Yi, Min; Snyder, Wendy; Mehnert, Janice

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets Flt3配体通过扩大树突状细胞亚群增强对anti-DEC-205-NY-ESO-1疫苗的免疫反应

NATURE CANCER

IF28.5

2020-11-16

PREAI

Bhardwaj, Nina; Friedlander, Philip A.; Pavlick, Anna C.; Ernstoff, Marc S.; Gastman, Brian R.; Hanks, Brent A.; Curti, Brendan D.; Albertini, Mark R.; Luke, Jason J.; Blazquez, Ana B.; Balan, Sreekumar; Bedognetti, Davide; Beechem, Joseph M.; Crocker, Andrea S.; D'Amico, Leonard; Danaher, Patrick; Davis, Thomas A.; Hawthorne, Thomas; Hess, Bruce W.; Keler, Tibor; Lundgren, Lisa; Morishima, Chihiro; Ramchurren, Nirasha; Rinchai, Darawan; Salazar, Andres M.; Salim, Bob A.; Sharon, Elad; Vitale, Laura A.; Wang, Ena; Warren, Sarah; Yellin, Michael J.; Disis, Mary L.; Cheever, Martin A.; Fling, Steven P.

Genomic analysis of metastatic melanoma in an adult with giant congenital melanocytic nevus

PIGMENT CELL & MELANOMA RESEARCH

IF2.6

2020-03-10

PREAI

Chang, Li-Wei; Iqbal, Ramiz; Badal, Brateil; Bernstein, Daniel; Mendelson, Karen; Solovyov, Alexander; Friedlander, Philip; Phelps, Robert; Goodheart, Herbert; Desman, Garrett; Greenbaum, Benjamin D.; Celebi, Julide Tok

Early phase I clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) plus radiation in cancers involving the CNS

CANCER RESEARCH

IF16.6

2018-07-01

PREAI

Morgan, L. R.; Mahmood, T.; Weiner, R. S.; Kawauchi, R.; Bhandari, M.; Devisitty, K.; Herman, J.; Summe, R.; Ware, M. L.; Friedlander, P.; Rodgers, A. H.

Early clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in adolescents and young adults (AYA) with cancers

MOLECULAR CANCER THERAPEUTICS

IF5.5

2018-01-01

PREAI

Morgan, Lee Roy; Rodgers, Andrew H.; Weiner, Roy S.; Mahmood, Tallat; Ware, Marcus L.; Bhandari, Manish; Friedlander, Philip

Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report

JOURNAL OF IMMUNOTHERAPY

IF2.9

2018-01-01

PREAI

Zecchini, Julia M.; Kim, Sara; Yum, Kendra; Friedlander, Philip

RAPID EVOLUTION OF THYROID DYSFUNCTION IN PATIENTS TREATED WITH NIVOLUMAB

ENDOCRINE PRACTICE

IF4.6

2017-10-01

PREAI

O'Malley, Grenye; Lee, Hanna J.; Parekh, Samir; Galsky, Matthew D.; Smith, Cardinale B.; Friedlander, Philip; Yanagisawa, Robert T.; Gallagher, Emily J.

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2016-06-30

1.0K

OAAI

Nghiem, Paul T.; Bhatia, Shailender; Lipson, Evan J.; Kudchadkar, Ragini R.; Miller, Natalie J.; Annamalai, Lakshmanan; Berry, Sneha; Chartash, Elliot K.; Daud, Adil; Fling, Steven P.; Friedlander, Philip A.; Kluger, Harriet M.; Kohrt, Holbrook E.; Lundgren, Lisa; Margolin, Kim; Mitchell, Alan; Olencki, Thomas; Pardoll, Drew M.; Reddy, Sunil A.; Shantha, Erica M.; Sharfman, William H.; Sharon, Elad; Shemanski, Lynn R.; Shinohara, Michi M.; Sunshine, Joel C.; Taube, Janis M.; Thompson, John A.; Townson, Steven M.; Yearley, Jennifer H.; Topalian, Suzanne L.; Cheever, Martin A.

Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma 评估转移性黑色素瘤患者维利帕尼 (ABT-888) 和替莫唑胺的随机II期研究

ANNALS OF ONCOLOGY

IF65.4

2015-10-01

OAAI

Middleton, M. R.; Friedlander, P.; Hamid, O.; Daud, A.; Plummer, R.; Falotico, N.; Chyla, B.; Jiang, F.; McKeegan, E.; Mostafa, N. M.; Zhu, M.; Qian, J.; McKee, M.; Luo, Y.; Giranda, V. L.; McArthur, G. A.

Activity of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Nghiem, P.; Bhatia, S.; Daud, A.; Friedlander, P.; Kluger, H.; Kohrt, H.; Kudchadkar, R.; Lipson, E.; Lundgren, L.; Margolin, K.; Reddy, S.; Shantha, E.; Sharfman, W.; Sharon, E.; Thompson, J.; Topalian, S.; Cheever, M.

Results from the early cancer clinical trials for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN)

CANCER RESEARCH

IF16.6

2015-08-01

PREAI

Weiner, Roy S.; Friedlander, P.; Mahmood, T.; Hormigo, Adilia; Gordon, C.; Saenger, Y.; Ware, M. L.; Thirukonda, V. K.; Patel, V. M.; Cosgriff, T. J.; Rodgers, A. H.; Morgan, L. R.; Bastian, G.

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC 关键的基底细胞癌 (BCC) 研究: vismodegib在晚期BCC中的疗效和安全性的12个月更新

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2015-06-01

171

PREAI

Sekulic, Aleksandar; Migden, Michael R.; Lewis, Karl; Hainsworth, John D.; Solomon, James A.; Yoo, Simon; Arron, Sarah T.; Friedlander, Philip A.; Marmur, Ellen; Rudin, Charles M.; Chang, Anne Lynn S.; Dirix, Luc; Hou, Jeannie; Yue, Huibin; Hauschild, Axel

A phase I cancer clinical trial for 4-demethyl-4cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) IND 68.876

CANCER RESEARCH

IF16.6

2014-10-01

PREAI

Weiner, Roy S.; Friedlander, Philip; Gordon, Craig; Saenger, Yvonne; Mohmood, Tallat; Ware, Marcus; Rogers, A. H.; Bastian, Gerard; Urien, S.; Morgan, L. R.

研究方向